• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性内肽酶抑制剂SQ 28,603在清醒猴体内的评估。

Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.

作者信息

Seymour A A, Abboa-Offei B, Asaad M M, Rogers W L

机构信息

Department of Pharmacology, Squibb Institute for Medical Research, Princeton, NJ 08543-4000.

出版信息

Can J Physiol Pharmacol. 1991 Oct;69(10):1609-17. doi: 10.1139/y91-238.

DOI:10.1139/y91-238
PMID:1663819
Abstract

The potent neutral endopeptidase inhibitor SQ 28,603 (N-(2-(mercaptomethyl)-1-oxo-3-phenylpropyl)-beta-alanine) significantly increased excretion of sodium from 4.9 +/- 2.3 to 14.3 +/- 2.1 muequiv./min and cyclic 3',5'-guanosine monophosphate from 118 +/- 13 to 179 +/- 18 pmol/min after intravenous administration of 300 mumol/kg (approximately 80 mg/kg) in conscious female cynomolgus monkeys. SQ 28,603 did not change blood pressure or plasma atrial natriuretic peptide concentrations in the normal monkeys. In contrast, 1-h infusions of 3, 10, or 30 pmol.kg-1.min-1 of human atrial natriuretic peptide lowered blood pressure by -3 +/- 4, -9 +/- 4, and -27 +/- 3 mmHg (1 mmHg = 133.322 Pa), increased cyclic guanosine monophosphate excretion from 78 +/- 11 to 90 +/- 6, 216 +/- 33, and 531 +/- 41 pmol/min, and raised plasma atrial natriuretic peptide from 7.2 +/- 0.7 to 21 +/- 4, 62 +/- 12, and 192 +/- 35 fmol/mL without affecting sodium excretion. In monkeys receiving 10 pmol.kg-1.min-1 of atrial natriuretic peptide, 300 mumol/kg of SQ 28,603 reduced mean arterial pressure by -13 +/- 5 mmHg and increased sodium excretion from 6.6 +/- 3.2 to 31.3 +/- 6.0 muequiv./min, cyclic guanosine monophosphate excretion from 342 +/- 68 to 1144 +/- 418 pmol/min, and plasma atrial natriuretic peptide from 124 +/- 8 to 262 +/- 52 fmol/mL. In conclusion, SQ 28,603 stimulated renal excretory function in conscious monkeys, presumably by preventing the degradation of atrial natriuretic peptide by neutral endopeptidase.

摘要

强效中性内肽酶抑制剂SQ 28,603(N-(2-(巯基甲基)-1-氧代-3-苯基丙基)-β-丙氨酸)在清醒雌性食蟹猴静脉注射300 μmol/kg(约80 mg/kg)后,显著增加了钠排泄量,从4.9±2.3增加到14.3±2.1 μeq/分钟,环磷酸鸟苷从118±13增加到179±18 pmol/分钟。SQ 28,603在正常猴子中未改变血压或血浆心钠素浓度。相比之下,以3、10或30 pmol·kg-1·min-1的速率静脉输注人的心钠素1小时,可使血压分别降低-3±4、-9±4和-27±3 mmHg(1 mmHg = 133.322 Pa),使环磷酸鸟苷排泄量从78±11增加到90±6、216±33和531±41 pmol/分钟,并使血浆心钠素从7.2±0.7增加到21±4、62±12和192±35 fmol/mL,而不影响钠排泄。在接受10 pmol·kg-1·min-1心钠素的猴子中,300 μmol/kg的SQ 28,603使平均动脉压降低-13±5 mmHg,并使钠排泄量从6.6±3.2增加到31.3±6.0 μeq/分钟,环磷酸鸟苷排泄量从342±68增加到1144±418 pmol/分钟,血浆心钠素从124±8增加到262±52 fmol/mL。总之,SQ 28,603可能通过防止中性内肽酶降解心钠素,刺激了清醒猴子的肾脏排泄功能。

相似文献

1
Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.中性内肽酶抑制剂SQ 28,603在清醒猴体内的评估。
Can J Physiol Pharmacol. 1991 Oct;69(10):1609-17. doi: 10.1139/y91-238.
2
Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
J Cardiovasc Pharmacol. 1991 Feb;17(2):296-304. doi: 10.1097/00005344-199102000-00016.
3
Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.在起搏诱导的心力衰竭清醒犬中抑制中性内肽酶3.4.24.11
Cardiovasc Res. 1993 Jun;27(6):1015-23. doi: 10.1093/cvr/27.6.1015.
4
Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.中性内肽酶3.4.24.11和血管紧张素转换酶抑制剂体内活性的决定因素。
J Pharmacol Exp Ther. 1996 Feb;276(2):708-13.
5
Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.SQ 29,072对心房利钠因子-(99-126)肾脏效应的增强作用。
Hypertension. 1989 Jul;14(1):87-97. doi: 10.1161/01.hyp.14.1.87.
6
Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.中性内肽酶3.4.24.11抑制剂SQ 28,603对猴和大鼠脑钠肽的增强作用。
J Pharmacol Exp Ther. 1992 Jul;262(1):60-70.
7
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.在起搏诱导的心力衰竭清醒犬中抑制中性内肽酶3.4.24.11和血管紧张素转换酶期间的全身血流动力学、肾功能和激素水平
J Pharmacol Exp Ther. 1993 Aug;266(2):872-83.
8
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.大鼠主动脉腔静脉分流术后急性和慢性中性内肽酶抑制作用
Hypertension. 1996 Jun;27(6):1259-66. doi: 10.1161/01.hyp.27.6.1259.
9
Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.大鼠对心房利钠肽、内肽酶24.11抑制剂及C型心房钠尿肽受体配体的反应
Br J Pharmacol. 1992 Sep;107(1):50-7. doi: 10.1111/j.1476-5381.1992.tb14462.x.
10
Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
J Pharmacol Exp Ther. 1991 Mar;256(3):1002-9.